HuagongsheHuagongshe Chemistry Print Report · For research reference only
(1-methylpiperidin-2-yl)methanamine → HCID 59605291, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (1-methylpiperidin-2-yl)methanamine | HCID 2794677 | — |
| Reactant | 4-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine | HCID 59605812 | — |
| Product | HCID 59605291 | HCID 59605291 | — |
Reaction Steps
4-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine (50 mg) was reacted with (1-methylpiperidin-2-yl)methanamine via General Procedure E to give 4.1 mg of 282 following reverse phase purification. MS (Q1) 490.2 (M)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08173650B2 |
| Source dataset | uspto-grants-2012_05 |
| ORD ID | ord-0f24bf4cbc384d4fb5c5edefcac27369 |
| Source note | uspto-grants-2012_05 |